Arcturus Therapeutics Holdings - stock earnings
ARCT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -8.6 million USD | 28.2 million USD |
| 2023Q3 | -16.2 million USD | 43.4 million USD |
| 2023Q2 | -52.6 million USD | 9.6 million USD |
| 2023Q1 | 50.8 million USD | 79.7 million USD |
| 2022Q4 | 117.3 million USD | 160.0 million USD |
| 2022Q3 | -34.5 million USD | 13.4 million USD |
| 2022Q2 | -21.0 million USD | 27.1 million USD |
| 2022Q1 | -52.0 million USD | 5.2 million USD |
| 2021Q4 | -38.7 million USD | 5.8 million USD |
| 2021Q3 | -54.1 million USD | 2.4 million USD |
| 2021Q2 | -54.6 million USD | 2.0 million USD |
| 2021Q1 | -56.3 million USD | 2.1 million USD |
| 2020Q4 | -31.1 million USD | 2.2 million USD |
| 2020Q3 | -21.0 million USD | 2.3 million USD |
| 2020Q2 | -10.3 million USD | 2.3 million USD |
| 2020Q1 | -9.8 million USD | 2.6 million USD |
| 2019Q4 | -11.0 million USD | 3.0 million USD |
| 2019Q3 | -7.4 million USD | 3.3 million USD |
| 2019Q2 | -685000 USD | 10.2 million USD |
| 2019Q1 | -6.9 million USD | 4.4 million USD |
| 2018Q4 | -1.0 million USD | 7.6 million USD |
| 2018Q3 | -4.3 million USD | 3.4 million USD |
| 2018Q2 | -10.0 million USD | 2.4 million USD |
| 2018Q1 | -6.6 million USD | 2.4 million USD |
| 2017Q4 | -1.1 million USD | 13.0 million USD |
| 2017Q3 | -2.6 million USD | 3.3 million USD |
| 2017Q2 | -3.7 million USD | 3.8 million USD |
| 2017Q1 | -3.5 million USD | 3.9 million USD |
| 2016Q4 | -5.9 million USD | 20.4 million USD |
| 2016Q3 | -7.8 million USD | ? USD |
| 2016Q2 | -5.8 million USD | ? USD |
| 2016Q1 | -5.1 million USD | ? USD |
| 2015Q4 | -4.9 million USD | ? USD |
| 2015Q3 | -4.3 million USD | ? USD |
| 2015Q2 | -5.1 million USD | ? USD |
| 2015Q1 | -5.2 million USD | ? USD |
| 2014Q4 | -6.8 million USD | ? USD |
| 2014Q3 | -10.5 million USD | ? USD |
| 2014Q2 | -7.8 million USD | ? USD |
| 2014Q1 | -7.8 million USD | ? USD |
| 2013Q4 | -5.7 million USD | ? USD |
| 2013Q3 | -3.1 million USD | ? USD |
| 2013Q2 | -1.3 million USD | ? USD |
| 2013Q1 | -377000 USD | ? USD |
| 2012Q4 | -295000 USD | ? USD |
| 2012Q3 | -283000 USD | ? USD |
| 2012Q2 | -440000 USD | ? USD |
ARCT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -29.7 million USD | 157.7 million USD |
| 2022 | 9.3 million USD | 205.8 million USD |
| 2021 | -206.9 million USD | 12.4 million USD |
| 2020 | -71.4 million USD | 9.5 million USD |
| 2019 | -25.7 million USD | 20.8 million USD |
| 2018 | -21.8 million USD | 15.8 million USD |
| 2017 | -10.9 million USD | 13.0 million USD |
| 2016 | -24.6 million USD | ? USD |
| 2015 | -19.4 million USD | 6.1 million USD |
| 2014 | -32.8 million USD | ? USD |
| 2013 | -10.5 million USD | ? USD |
| 2012 | -1.6 million USD | ? USD |
| 2011 | -3.9 million USD | ? USD |
ARCT
Price: $26.55
52 week price:
Earnings Per Share: -1.12 USD
P/E Ratio: 10.54
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 359653
Ebitda: -2.9 millionMarket Capitalization: 860.5 million
Average Dividend Frequency: 1